Brighthouse Financial and Aquarian Parent are discussing extending the merger deadline after required insurance regulatory approvals were not expected by December 6, 2026.
BHF · Brighthouse Financial, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Brighthouse Financial reported third-quarter net income available to shareholders of $302 million, or $5.21 per diluted share, and is discussing extending its Aquarian Capital merger after regulatory approvals were not expected by December 6, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings non-GAAP | 527M | the third quarter of 2026 | — |
|
|
|||
| Adjusted earnings (Annuities) non-GAAP | $974M | nine months ended September 30, 2026 | — |
|
|
|||
| Adjusted earnings (Life) non-GAAP | 91M | the third quarter of 2026 | — |
| Adjusted earnings (loss) non-GAAP | $527M | the three months ended September 30, 2026 | — |
| Adjusted earnings (loss) per common share non-GAAP | $9.12 | the three months ended September 30, 2026 | — |
|
|
|||
| Adjusted earnings (Run-off) non-GAAP | 166M | the third quarter of 2026 | — |
| Adjusted earnings, less notable items non-GAAP | $722M | Nine months ended September 30, 2026 | — |
|
|
|||
| Adjusted earnings, less notable items per common share non-GAAP | $3.68 | the three months ended September 30, 2026 | — |
|
|
|||
| Adjusted earnings, less notable items per diluted share non-GAAP | $3.68 | the third quarter of 2026 | — |
| Adjusted net investment income non-GAAP | 1.31B | the third quarter of 2026 | — |
|
|
|||
| Adjusted net investment income yield non-GAAP | 4.41% | the third quarter of 2026 | — |
|
|
|||
| Adjusted return on common equity, excluding AOCI non-GAAP | 14.1% | Three Months Ended September 30, 2026 | — |
|
|
|||
| Annuity sales | 2.4B | the third quarter of 2026 | — |
|
|
|||
| Book value per common share non-GAAP | $57.59 | As of September 30, 2026 | — |
| Book value per common share, excluding AOCI non-GAAP | $161.36 | As of September 30, 2026 | — |
| Book value, excluding AOCI | 9.3B | As of September 30, 2026 | — |
| Combined total adjusted capital | $4.8B | As of September 30, 2026 | — |
| Corporate expenses | 204M | the third quarter of 2026 | — |
| Holding company liquid assets | 1B | As of September 30, 2026 | — |
| Institutional spread margin business account balance, end of period | $9.08B | September 30, 2026 | — |
| Life Insurance in-force, before reinsurance (Universal Life with Secondary Guarantees) | $64.98B | September 30, 2026 | — |
| Life sales | 36M | the third quarter of 2026 | — |
|
|
|||
| Net favorable notable items non-GAAP | 314M | the third quarter of 2026 | — |
| Percent allocated to balanced funds | 40.17% | Three months ended September 30, 2026 | — |
| Percent allocated to bond funds/other funds | 9.09% | Three months ended September 30, 2026 | — |
| Percent allocated to equity funds | 33.31% | Three months ended September 30, 2026 | — |
| Percent allocated to target volatility funds | 17.43% | Three months ended September 30, 2026 | — |
| Return on common equity, excluding AOCI non-GAAP | 6.6% | Three Months Ended September 30, 2026 | — |
|
|
|||
| Shield Level Annuities sales | 2.1B | the third quarter of 2026 | — |
|
|
|||
| Statutory combined total adjusted capital | 4.8B | As of September 30, 2026 | — |
| Total adjusted expenses non-GAAP | $1.41B | Three months ended September 30, 2026 | — |
| Total adjusted revenues non-GAAP | $2.1B | Three months ended September 30, 2026 | — |
| Total corporate expenses | $204M | Three Months Ended September 30, 2026 | — |
|
|
|||
| Total fixed and income annuity sales | $382M | nine months ended September 30, 2026 | — |
|
|
|||
| Total life sales | $107M | nine months ended September 30, 2026 | — |
| Total notable items | -$314M | three months ended September 30, 2026 | — |
| Total Quarterly VA separate account gross returns | -1.19% | three months ended September 30, 2026 | — |
| Total variable and Shield Level annuity sales | $6.63B | nine months ended September 30, 2026 | — |
|
|
|||
| Universal Life with Secondary Guarantees account value, end of period | $4.25B | September 30, 2026 | — |
| Adjusted earnings (Total) non-GAAP | $497M | Six Months Ended June 30, 2026 | — |
| Fixed Annuities account value, end of period | $16.95B | Q2 2026 | — |
| Income annuity insurance liabilities, end of period | $4.82B | Q2 2026 | — |
| Institutional group annuities account value, end of period | $660M | Q2 2026 | — |
| Term Life insurance in-force, before reinsurance | $300.62B | Q2 2026 | — |
| Term Life insurance in-force, net of reinsurance | $249.86B | Q2 2026 | — |
| Universal and variable universal life account value, end of period | $2.65B | Q2 2026 | — |
| Universal and Variable Universal Life insurance in-force, before reinsurance | $40.45B | Q2 2026 | — |
| Universal and Variable Universal Life insurance in-force, net of reinsurance | $31.23B | Q2 2026 | — |
| Variable and Shield Level Annuities account value, end of period | $132.98B | Q2 2026 | — |
| Variable and Shield Level Annuities net flows | -$2.42B | Q2 2026 | — |
| Variable universal life account value, end of period | $7.21B | Q2 2026 | — |
| Whole Life insurance in-force, before reinsurance | $15.75B | Q2 2026 | — |
| Whole Life insurance in-force, net of reinsurance | $2.71B | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BHF
this stock
Brighthouse Financial, Inc.
|
$2.42B | -35.1% | +43.2% | 4.3 | 11.7% |
|
CILJF
China Life Insurance Co Ltd
|
$72.07B | -26.1% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$71.05B | +18.6% | — | — | 0.8% |
|
MET
Metlife Inc
|
$62.71B | +26.4% | +8.6% | 13.0 | 1.7% |
|
AFL
Aflac Inc
|
$61.96B | +13.6% | -9.3% | 18.4 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BHF | -7.2% | -10.4% | -32.7% | -4.2% | -35.1% |
| SPY | -3.9% | -5.6% | -3.5% | -3.4% | +7.1% |
| vs SPY | -3.3% | -4.9% | -29.3% | -0.8% | -42.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.